• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

《关于“ThyGeNEXT®+ThyraMIR®检测与甲状腺切除术后组织病理学的假阴性率及一致性”的勘误》[《临床转化内分泌学》40 (2025) 100396]

Corrigendum to "False negative rate and concordance of ThyGeNEXT®+ThyraMIR® testing with post-thyroidectomy histopathology" [J. Clin. Translat. Endocrinol. 40 (2025) 100396].

作者信息

Mohammed Sobrina S, Mettman Daniel, Garcia-Touza Mariana, Drees Betty, Ridella Maricel

机构信息

University of Missouri-Kansas City School of Medicine, Division of Endocrinology, Department of Internal Medicine, 2301 Holmes Street, Kansas City, MO 64108, USA.

Kansas City Veterans Affairs Medical Center, Department of Pathology, 4801 Linwood Blvd, Kansas City, MO 64128, USA.

出版信息

J Clin Transl Endocrinol. 2025 May 15;40:100397. doi: 10.1016/j.jcte.2025.100397. eCollection 2025 Jun.

DOI:10.1016/j.jcte.2025.100397
PMID:40524841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12168210/
Abstract

[This corrects the article DOI: 10.1016/j.jcte.2025.100396.].

摘要

[本文更正了文章的数字对象标识符：10.1016/j.jcte.2025.100396。]

相似文献

1
Corrigendum to "False negative rate and concordance of ThyGeNEXT®+ThyraMIR® testing with post-thyroidectomy histopathology" [J. Clin. Translat. Endocrinol. 40 (2025) 100396].《关于“ThyGeNEXT®+ThyraMIR®检测与甲状腺切除术后组织病理学的假阴性率及一致性”的勘误》[《临床转化内分泌学》40 (2025) 100396]
J Clin Transl Endocrinol. 2025 May 15;40:100397. doi: 10.1016/j.jcte.2025.100397. eCollection 2025 Jun.
2
False negative rate and concordance of ThyGeNEXT®+ThyraMIR® testing with post-thyroidectomy histopathology.ThyGeNEXT®+ThyraMIR®检测与甲状腺切除术后组织病理学检查的假阴性率及一致性
J Clin Transl Endocrinol. 2025 Apr 24;40:100396. doi: 10.1016/j.jcte.2025.100396. eCollection 2025 Jun.
3
Corrigendum to "Prediction of BRAF and TERT status in PTCs by machine learning-based ultrasound radiomics methods: A multicenter study" [J. Clin. Translat. Endocrinol. 40 (2025) 100390].《基于机器学习的超声放射组学方法预测甲状腺乳头状癌中BRAF和TERT状态：一项多中心研究》的勘误 [《临床转化内分泌学》40 (2025) 100390]
J Clin Transl Endocrinol. 2025 Apr 14;40:100394. doi: 10.1016/j.jcte.2025.100394. eCollection 2025 Jun.
4
Corrigendum to "Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes" [J. Clin. Translat. Endoc. 36C (2024) 100343].《司美格鲁肽在肾移植后2型糖尿病或移植后糖尿病患者中的安全性和有效性》勘误 [《临床转化内分泌学》36C卷（2024年）100343]
J Clin Transl Endocrinol. 2024 Jul 9;38:100360. doi: 10.1016/j.jcte.2024.100360. eCollection 2024 Dec.
5
Erratum regarding missing Declaration of Competing Interest statements in previously published articles.关于之前发表文章中缺失利益冲突声明的勘误。
J Clin Transl Endocrinol. 2020 Dec 17;23:100242. doi: 10.1016/j.jcte.2020.100242. eCollection 2021 Mar.
6
Erratum regarding missing Declaration of Competing Interest statements in previously published articles.关于已发表文章中缺失利益冲突声明的勘误。
J Clin Transl Endocrinol. 2020 Dec 17;23:100246. doi: 10.1016/j.jcte.2020.100246. eCollection 2021 Mar.
7
Diagnostic Performance of Afirma and Interpace Diagnostics Genetic Testing in Indeterminate Thyroid Nodules: A Single Center Study.Afirma和Interpace诊断基因检测在甲状腺结节诊断中的性能：一项单中心研究
Cancers (Basel). 2023 Mar 31;15(7):2098. doi: 10.3390/cancers15072098.
8
Corrigendum to "Chk2 deletion rescues bone loss and cellular senescence induced by Bmi1 deficiency via regulation of Cyp1a1" [J Orthop Translat, 52 (2025) 360-375 /doi.org/10.1016/j.jot.2025.04.014].《Chk2缺失通过调控Cyp1a1挽救Bmi1缺乏诱导的骨质流失和细胞衰老》的勘误[《骨科转化医学》，第52卷（2025年），第360 - 375页/doi.org/10.1016/j.jot.2025.04.014]
J Orthop Translat. 2025 Jun 4;53:37. doi: 10.1016/j.jot.2025.05.009. eCollection 2025 Jul.
9
Corrigendum to 'Regenerative technologies to bed side: Evolving the regulatory' [J Orthop Translat 9 (2017) 1-7].《再生技术走向临床：监管的演变》[《骨科翻译》9 (2017) 1 - 7]勘误
J Orthop Translat. 2018 Feb 3;12:93. doi: 10.1016/j.jot.2017.12.005. eCollection 2018 Jan.
10
Molecular Testing Using ThyGeNEXT/ThyraMIR in Thyroid Nodules With Indeterminate Cytology: A Single Medical Institute Experience.在甲状腺结节细针穿刺结果不确定时使用ThyGeNEXT/ThyraMIR进行分子检测：一家医疗机构的经验
Diagn Cytopathol. 2025 Jul;53(7):351-356. doi: 10.1002/dc.25474. Epub 2025 Apr 6.